[HTML][HTML] Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
P Pi, Z Zeng, L Zeng, B Han, X Bai, S Xu - Frontiers in Pharmacology, 2023 - frontiersin.org
As the outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought …
(SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought …
New therapeutic approaches against pulmonary fibrosis
D Yu, Y Xiang, T Gou, R Tong, C Xu, L Chen… - Bioorganic …, 2023 - Elsevier
Pulmonary fibrosis is the end-stage change of a large class of lung diseases characterized
by the proliferation of fibroblasts and the accumulation of a large amount of extracellular …
by the proliferation of fibroblasts and the accumulation of a large amount of extracellular …
[HTML][HTML] Single-cell RNA sequencing analysis of lung cells in COVID-19 patients with diabetes, hypertension, and comorbid diabetes-hypertension
X Zhang, X Deng, L Zhang, P Wang, X Tong… - Frontiers in …, 2023 - frontiersin.org
Background There is growing evidence that the lung is a target organ for injury in diabetes
and hypertension. There are no studies on the status of the lungs, especially cellular …
and hypertension. There are no studies on the status of the lungs, especially cellular …
[HTML][HTML] Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease
D Visca, R Centis, E Pontali… - … of Tuberculosis and …, 2023 - ingentaconnect.com
BACKGROUND: The aim of these clinical standards is to provide guidance on 'best
practice'care for the diagnosis, treatment and prevention of post-COVID-19 lung disease …
practice'care for the diagnosis, treatment and prevention of post-COVID-19 lung disease …
[HTML][HTML] Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis
C Mo, M Yan, XX Tang, S Shichino… - Frontiers in Cell and …, 2024 - frontiersin.org
Organ fibrosis poses a significant threat to human health, contributing to over 30% of
diseases that result in disability and mortality (Rockey et al., 2015; Zhou et al., 2022; …
diseases that result in disability and mortality (Rockey et al., 2015; Zhou et al., 2022; …
[HTML][HTML] Rehabilitative interventions in patients with persistent post COVID-19 symptoms—a review of recent advances and future perspectives
R Gloeckl, D Leitl, T Schneeberger, I Jarosch… - European Archives of …, 2023 - Springer
The SARS-CoV-2 pandemic has not only caused millions of deaths but left also millions of
people with persistent symptoms behind. These long-term COVID-19 sequelae cause a …
people with persistent symptoms behind. These long-term COVID-19 sequelae cause a …
The regenerative power of stem cells: treating bleomycin-induced lung fibrosis
A Vats, P Chaturvedi - Stem Cells and Cloning: Advances and …, 2023 - Taylor & Francis
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease with no known
cure, characterized by the formation of scar tissue in the lungs, leading to respiratory failure …
cure, characterized by the formation of scar tissue in the lungs, leading to respiratory failure …
[HTML][HTML] Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China
S Li, X Duan, N Jiang, AJ Jeyarajan, CA Warner… - International …, 2023 - Elsevier
Background The differences in host antiviral gene expression and disease severity between
vaccinated and non-vaccinated coronavirus disease 2019 (COVID-19) patients are not well …
vaccinated and non-vaccinated coronavirus disease 2019 (COVID-19) patients are not well …
[HTML][HTML] Medicinal Plants for the Management of Post-COVID-19 Fatigue: a Literature Review on the Role and Mechanisms
Y Chen, C Zhang, Y Feng - Journal of Traditional and Complementary …, 2024 - Elsevier
Background COVID-19 infection has a lasting impact on human health, which is known as
post-COVID-19 conditions. Fatigue is one of the most commonly reported post-COVID-19 …
post-COVID-19 conditions. Fatigue is one of the most commonly reported post-COVID-19 …
Tofacitinib and pirfenidone as rescue therapies for severe COVID‐19 in a patient with previously stable interstitial lung disease associated with Sjögren syndrome
YC Tsao, SH Chuang, CW Tseng - International Journal of …, 2024 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) can lead to pulmonary fibrosis due to the
inflammatory process in the lung, resulting in a series of respiratory consequences. Patients …
inflammatory process in the lung, resulting in a series of respiratory consequences. Patients …